INTERPACE DIAGNOSTICS GROUP's ticker is IDXG and the CUSIP is 46062X204. A total of 17 filers reported holding INTERPACE DIAGNOSTICS GROUP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $599,000 | -36.7% | 1,197,631 | 0.0% | 0.00% | – |
| Q3 2019 | $946,000 | +12.1% | 1,197,631 | +2.8% | 0.00% | – |
| Q2 2019 | $844,000 | -9.3% | 1,164,686 | +0.1% | 0.00% | – |
| Q1 2019 | $931,000 | +29.8% | 1,163,986 | +29.8% | 0.00% | – |
| Q4 2018 | $717,000 | -45.9% | 896,564 | +4.2% | 0.00% | – |
| Q3 2018 | $1,325,000 | +71.9% | 860,510 | -0.6% | 0.00% | – |
| Q2 2018 | $771,000 | +15.9% | 865,972 | +15.0% | 0.00% | – |
| Q1 2018 | $665,000 | -4.3% | 753,276 | +10.6% | 0.00% | – |
| Q4 2017 | $695,000 | +234.1% | 680,893 | +406.1% | 0.00% | – |
| Q3 2017 | $208,000 | +252.5% | 134,525 | +104.4% | 0.00% | – |
| Q2 2017 | $59,000 | -51.6% | 65,817 | +41.3% | 0.00% | – |
| Q1 2017 | $122,000 | +110.3% | 46,579 | +257.4% | 0.00% | – |
| Q4 2016 | $58,000 | – | 13,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,839,708 | $1,624,000 | 0.10% |
| LINCOLN CAPITAL CORP | 10,350 | $9,000 | 0.01% |
| WEDBUSH SECURITIES INC | 53,000 | $47,000 | 0.01% |
| NORTHERN TRUST CORP | 26,258 | $23,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 84,995 | $75,000 | 0.00% |
| CIBC Private Wealth Group, LLC | 200 | $0 | 0.00% |
| CREDIT SUISSE AG/ | 13,000 | $11,000 | 0.00% |
| MORGAN STANLEY | 615 | $1,000 | 0.00% |
| BlackRock Inc. | 1,158,352 | $1,022,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 22,600 | $20,000 | 0.00% |